January 9, 2012

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 62 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2011 ACS

Patent Number: US 8067594
Title: Process for the production of benzopyran-2-ol derivatives
Inventor(s): Ahman, Jens Bertil; Dillon, Barry Richard; Pettman, Alan John
Patent Assignee(s): Pfizer Limited, UK
Source: PCT Int. Appl., 37 pp. CODEN: PIXXD2
Language: English

Abstract:

The invention provides a process for the production of a compound of formula (I), wherein Y is selected from CH3, CH2OH, CH2CH2OH, CH2Br and Br; comprising the steps of: (i) reacting a compound of formula (II), wherein OX is OH or O- M+, in which M+ is a cation selected from Li+, Na+ and K+, and Y is as defined above; with trans-cinnamaldehyde, in the presence of a secondary amine compound; then (ii) treating the product of the preceding step with acid to afford I.  Compds. I are intermediates useful in the production of tolterodine and fesoterodine, which are useful in the treatment of overactive bladder.

Please note:  Abstracts for patent records in CAplus are routinely enhanced to better describe the claimed invention. In this example, CAS enhanced the abstract using additional information found in the patent.

 

View the full-text U.S. patent from USPTO.

Recent News

   
    July 28, 2014 | Latest Release of New STN Now
    Available, Expands Global Patent Coverage and
    Enhances Search Capabilities
   
    June 30, 2014 | CHEMCATS on STN Enhanced with
    New Search and Display Fields and More Frequent
    Updates
    
    June 18, 2014
| SciFinder and ChemDraw Software
    Connection Now Available to Customers

                                                                     More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org